Presentations we supply
- Tablet 100 mg
- Tablet 150 mg
Tell us whether you need the originator brand or a generic, the strength, pack and quantity, and the destination country.
Send Enquiry for ErlotinibReference information
Summarised from the product information for Tarceva. Always follow the product information approved in your own country.
- Active substance
- Erlotinib
- Pharmacotherapeutic group
- Antineoplastic agent, protein kinase inhibitor (ATC code L01EB02)
- Authorised uses
- First-line locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR activating mutations
- Switch maintenance in EGFR-mutation NSCLC with stable disease after first-line chemotherapy
- NSCLC after at least one prior chemotherapy regimen has failed
- Metastatic pancreatic cancer, with gemcitabine
- Storage (unopened)
- No special storage conditions.
- Shelf life (unopened)
- 4 years
- Container and pack
- PVC blisters sealed with aluminium foil; packs of 30 tablets
Supply from Bio Bridge Pharma
- The registration route and import licence are confirmed for your destination before we make an offer.
- Documents agreed before you order, such as the batch certificate of analysis and a CoPP where your regulator needs one.
- Named patient supply where the destination country's rules allow it.
Sources
- Product information for Tarceva: www.ema.europa.eu